From: Cluster analysis of sputum cytokine-high profiles reveals diversity in T(h)2-high asthma patients
CLUSTER | 1 | 2 | 3 | 4 | 5 | P value |
---|---|---|---|---|---|---|
Subjects (n=) | 24 | 16 | 8 | 25 | 132 | |
Age (years) | 44.0 ± 13.4 | 47.3 ± 14.1 | 39.0 ± 15.4 | 38.0 ± 12.7 | 40.2 ± 12.7 | 0.14 |
Gender (M/F) | 12/12 | 6/10 | 4/4 | 11/14 | 62/70 | 0.95 |
Body Mass Index | 22.5–26.8–28.8 | 21.2–25.4–29.9 | 20.7–23.5–30.9 | 21.9–23.6–26.0 | 21.8–24.3–28.7 | 0.55 |
Active smoking (%) | 9 | 0 | 0 | 19 | 19 | 0.27 |
Atopy (%) | 73 | 62 | 88 | 73 | 80 | 0.54 |
Steroid-naive (%) | 8 | 18 | 12 | 20 | 23 | 0.82 |
Inhaled steroids only (%) | 79 | 75 | 50 | 68 | 68 | 0.58 |
Inhaled and oral steroids (%) | 13 | 7 | 38 | 12 | 9 | 0.15 |
FEV1, % predicted | 86.0 ± 17.7† | 93.9 ± 17.5 | 95.6 ± 18.8 | 95.2 ± 21.4 | 96.1 ± 18.7 | 0.21 |
FEV1/FVC | 69.0 ± 12.0 | 72.5 ± 8.1 | 71.3 ± 13.1 | 71.3 ± 13.4 | 73.1 ± 11.3 | 0.57 |
PEF, % predicted | 90.0 ± 19.7 | 91.8 ± 18.5 | 96.9 ± 26.6 | 88.8 ± 26.7 | 97.5 ± 19.5 | 0.30 |
FEF25–75, % predicted | 53.5 ± 25.6 | 55.5 ± 23.0 | 67.2 ± 41.4 | 67.8 ± 35.4 | 67.2 ± 30.6 | 0.29 |
FENO (ppb) | 16.8–27.2–48.1† | 12.1–6.7–29.5 | 16.1–27.9–43.3 | 13.9–24.3–55.1 | 13.3–21.2–37.2 | 0.46 |
Sputum eosinophils (%) | 0.6–2.0–31.1† | 0.2–1.0–8.0 | 0.0–1.0–4.0 | 0.0–0.8–2.0 | 0.0–1.0–4.0††† | 0.36 |
Sputum neutrophils (%) | 23.5–51.9–81.6*,† | 29.5–64.0–73.8 | 22.0–32.0–62.4 | 37.0–55.0–77.9**,†† | 11.8–24.8–49.5† | <0.0001 |